
|Articles|May 16, 2020
ASCRS 2020: New solutions for patient, physician access from Sun Pharmaceuticals
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Mark Hagler, senior vice president, head of Ophthalmics, Oncology & LTC at Sun Pharmaceuticals, on the company's ongoing research and portfolio, as well as how its operations and employees are continuing to manage and adapt amid the coronavirus pandemic, during the 2020 ASCRS virtual meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA clears BVI’s FineVision HP trifocal IOL for the US market
2
AAO 2025: A practice’s experience with connecting "the why," building community for techs
3
Ophthalmology over the decades: A catalyst of innovation in the 1970s
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5